Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford is to take part in three new government-funded projects designed to help universities collaborate with each other, and with external organisations, to boost research commercialisation.

None

Image courtesy of Shutterstock

Healthy ageing, the internet of things, and commercialisation in the social sciences are the three themes with involvement from Oxford academics. Oxford is leading the programme on healthy ageing, is a partner in the Sheffield University-led internet of things project, and will also participate in the social sciences initiative led by LSE.

The projects are funded via Research England (formerly the Higher Education Funding Council for England) through its Connecting Capability Fund (CCF). This £100m fund supports university collaboration in research commercialisation with the aims of sharing good practice across the higher education sector, forging external technological, industrial and regional partnerships, and helping deliver the government's industrial strategy priorities.

Oxford recently launched its 150th spinout company based on University research. In 2018 alone, six new companies have been formed and more than £150m has been raised in external investment.

Professor Chas Bountra of Oxford's Nuffield Department of Clinical Medicine is leading the healthy ageing programme, titled UK SPINE KE and also involving Birmingham and Dundee universities. Announced last autumn in the first wave of CCF awards, the £4.82m project will establish a UK-wide network across universities, businesses and the NHS focused on improving health in old age.

Find out more (University of Oxford website)

Similar stories

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Major funding for Oxford will help find new cancer treatments

Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.